BHTG BioHiTech Global Inc

(Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form N-SAR ¨ Form N-CSR

For Period Ended: December 31, 2019

¨ Transition Report on Form 10-K

¨ Transition Report on Form 20-F

¨ Transition Report on Form 11-K

¨ Transition Report on Form 10-Q

¨ Transition Report on Form N-SAR

For the Transition Period Ended: ________________________

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I -- REGISTRANT INFORMATION

BIOHITECH GLOBAL, INC. 

Full Name of Registrant

Former Name if Applicable

80 Red Schoolhouse Road, Suite 101

Address of Principal Executive Office ( Street and Number )

Chestnut Ridge, New York 10977

City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra Sheets if Needed)

The Registrant could not complete the filing of its Annual Report on Form 10-K for the year ended December 31, 2019, within the prescribed time period due to its difficulty in obtaining required documentation required for the Form 10-K, which delay could not be eliminated by the Registrant without unreasonable effort and expense. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, the Registrant will file its Annual Report on Form 10-K no later than the fifteenth calendar day following the prescribed due date. 

PART IV -- OTHER INFORMATION

The consolidated results of operations for the year ended December 31, 2019 include the results of Entsorga West Virginia, LLC, (“EWV”) which the Company acquired a controlling interest in during the fourth quarter of 2018. The following provides the unaudited consolidated revenue and net loss attributable to Parent for the year ended December 31, 2019 and 2018:

Revenue for the year increased by $860,124 due to an increase of revenue from EWV of $1,111,071 realized during its commissioning and ramp up, an increase in digester related rental, service and maintenance fees of $145,162 offset by a decrease in revenue from digester equipment sales of $360,957 and a decrease in management advisory and other fees of $35,152. Loss from operations increased by $2,397,787 due to an increase in loss from operations of EWC of $3,088,474 during its commissioning and ramp up, offset by a net reduction in loss from operations from the remaining business units of $690,687. Net loss decreased by $4,467,159 due to the increase in loss from operations of $2,397,787, an increase in net interest expense of EWV of $2,050,961, offset by a decrease in net interest expense of the remaining business units of $1,326,393, a decrease in expense incurred in warrant valuation and conversions of $6,424,970, a decrease in equity loss in affiliate of $601,927 and a gain on sale of affiliate investment of $562,617. Net loss attributable to parent decreased by $7,201,162 due to a decrease in net loss of $4,467,159 and an increase in the net loss attributable to non-controlling interests of 2,734,003.

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

BioHiTech Global (NASDAQ:BHTG)
Historical Stock Chart
From Mar 2024 to Apr 2024

BioHiTech Global (NASDAQ:BHTG)
Historical Stock Chart
From Apr 2023 to Apr 2024